Paul Langlie Martin
Professor of Pediatrics
For most of my career in Pediatric Hematology/Oncology I have focused on the use of stem cell transplant for the treatment of pediatric leukemias (ALL, AML, CML and JMML) and other non-malignant blood disorders, such as sickle cell disease, hemaphagocytic disorders, Wiskott-Aldrich, aplastic anemia, Diamond-Blackfan Anemia, as well as inherited metabolic diseases. In addition to focusing on determining the best use of stem cell transplants for these disorders, I have also been involved in clinical research investigating the prevention and treatment of transplant related morbidity, particularly veno-occlusive disease of the liver, infections and diffuse alveolar hemorrhage. As study chair for the Children's Oncology Group protocol 9904, I was involved in the development, implementation and analysis of a large, international frontline study of childhood acute lymphoblastic leukemia. Results from this study show that a significant number of children with certain favorable cytogenetic abnormalities in their leukemic cells and who have a rapid response to their initial chemotherapy can expect to have a >95% chance of cure when treated with relatively low intensity chemotherapy.
I have concentrated on providing high quality care for high risk leukemia patients who require high intensity therapies, such as stem cell transplant and immunotherapy. As a member of the Pediatric Transplant and Cellular Therapy Division I provide clinical care for these patients. As a member of various cooperative groups and local PI for several drug trials, I have worked to provide better care and more specific therapies for the toxicities associated with stem cell transplant.
I have also collaborated with the Pediatric Immunology Division to provide a life-saving therapy for a small group of patients with thymic dysfunction, which causes severe immunodeficiency. Our clinical team now provides support during these patients hospital admissions for donor thymus tissue implantation.
I have concentrated on providing high quality care for high risk leukemia patients who require high intensity therapies, such as stem cell transplant and immunotherapy. As a member of the Pediatric Transplant and Cellular Therapy Division I provide clinical care for these patients. As a member of various cooperative groups and local PI for several drug trials, I have worked to provide better care and more specific therapies for the toxicities associated with stem cell transplant.
I have also collaborated with the Pediatric Immunology Division to provide a life-saving therapy for a small group of patients with thymic dysfunction, which causes severe immunodeficiency. Our clinical team now provides support during these patients hospital admissions for donor thymus tissue implantation.
Office Hours
Current Appointments & Affiliations
- Professor of Pediatrics, Pediatrics, Transplant and Cellular Therapy, Pediatrics 2021
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1996
Contact Information
- 2400 Pratt St, North Pavilion; Room 8045, Durham, NC 27705
- Box 102502 Med Ctr, Durham, NC 27710
-
paul.martin@duke.edu
(919) 668-1124
- Background
-
Education, Training, & Certifications
- Fellow, Pediatric Hematology/Oncology, Pediatrics, Yale University 1989 - 1992
- Resident, Pediatrics, Yale University 1988 - 1989
- Intern, Pediatrics, Yale University 1987 - 1988
- M.D., Washington University in St. Louis 1987
- Ph.D., Washington University in St. Louis 1987
-
Medical Licensure
- 37500. North Carolina. 2022
-
Previous Appointments & Affiliations
- Professor of Pediatrics, Pediatrics, Transplant and Cellular Therapy, Pediatrics 2017 - 2020
- Chief, Division of Pediatric Blood and Marrow Transplantation, Pediatrics, Transplant and Cellular Therapy, Pediatrics 2011 - 2020
- Associate Professor of Pediatrics, Pediatrics, Transplant and Cellular Therapy, Pediatrics 2006 - 2017
- Associate Clinical Professor of Pediatrics, Pediatrics, Transplant and Cellular Therapy, Pediatrics 2005 - 2006
- Assistant Professor of Pediatrics, Pediatrics, Transplant and Cellular Therapy, Pediatrics 1996 - 2005
- Instructor, Temporary in the Department of Pediatrics, Pediatrics, Hematology-Oncology, Pediatrics 1996
- Research
-
Selected Grants
- Hematology & Transfusion Medicine (T32) awarded by National Institutes of Health 1975 - 2026
- PHASE 3 STUDY EVALUATING GENE THERAPY BY TRANSPLANTATION OF AUTOLOGOUS CD34+ STEM CELLS TRANSDUCED EX VIVO WITH THE LENTIGLOBIN BB305 LENTIVIRAL VECTOR IN SUBJECTS WITH SEVERE SICKLE CELL DISEASE awarded by Bluebird Bio 2020 - 2023
- STELLAR Study awarded by Children's Healthcare of Atlanta 2019 - 2022
- A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia awarded by Novartis Pharmaceuticals Corporation 2015 - 2022
- A Phase 3, Randomized, Adaptive Study Comparing the Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant awarded by Jazz Pharmaceuticals 2017 - 2021
- PBMTC SUP 1601 Pathogen Identification in Pediatric HSCT awarded by Children's Hospital Los Angeles 2016 - 2021
- A Phase 2 Multicenter Single arm Study of Moxetumomab Pasudotox in Pediatric Subjects with Relapsed or Refractory pALL awarded by MedImmune, Inc. 2014 - 2016
- Pediatric Oncology Group (POG) awarded by National Institutes of Health 1983 - 2002
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Escherich, Carolin, Wenan Chen, Satoshi Miyamoto, Yui Namikawa, Wenjian Yang, David T. Teachey, Zhenhua Li, et al. “Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.” Blood Adv 7, no. 10 (May 23, 2023): 2177–80. https://doi.org/10.1182/bloodadvances.2022008563.Full Text Link to Item
-
Laetsch, Theodore W., Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, André Baruchel, et al. “Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.” J Clin Oncol 41, no. 9 (March 20, 2023): 1664–69. https://doi.org/10.1200/JCO.22.00642.Full Text Link to Item
-
Barth, Matthew, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, et al. “Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 20, no. 11 (November 2022): 1267–75. https://doi.org/10.6004/jnccn.2022.0057.Full Text Link to Item
-
Krishnamurti, Lakshmanan, Staci D. Arnold, Ann Haight, Allistair Abraham, Gregory Mt Guilcher, Tami John, Nitya Bakshi, et al. “Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.” Jmir Res Protoc 11, no. 7 (July 6, 2022): e36780. https://doi.org/10.2196/36780.Full Text Link to Item
-
Heston, Sarah M., Rebecca R. Young, John S. Tanaka, Kirsten Jenkins, Richard Vinesett, Frances M. Saccoccio, Paul L. Martin, Nelson J. Chao, and Matthew S. Kelly. “Risk Factors for CMV Viremia and Treatment-Associated Adverse Events Among Pediatric Hematopoietic Stem Cell Transplant Recipients.” Open Forum Infect Dis 9, no. 2 (February 2022): ofab639. https://doi.org/10.1093/ofid/ofab639.Full Text Link to Item
-
Sharma, Akshay, Sujuan Huang, Ying Li, Russell J. Brooke, Ibrahim Ahmed, Heather B. Allewelt, Persis Amrolia, et al. “Outcomes of pediatric patients with therapy-related myeloid neoplasms.” Bone Marrow Transplant 56, no. 12 (December 2021): 2997–3007. https://doi.org/10.1038/s41409-021-01448-x.Full Text Link to Item
-
Robles, Joanna M., Jesse D. Troy, Kristin M. Schroeder, Paul L. Martin, and Thomas W. LeBlanc. “Parental limited English proficiency in pediatric stem cell transplantation: Clinical impact and health care utilization.” Pediatr Blood Cancer 68, no. 9 (September 2021): e29174. https://doi.org/10.1002/pbc.29174.Full Text Link to Item
-
Ragoonanan, Dristhi, Sajad J. Khazal, Hisham Abdel-Azim, David McCall, Branko Cuglievan, Francesco Paolo Tambaro, Ali Haider Ahmad, et al. “Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.” Nat Rev Clin Oncol 18, no. 7 (July 2021): 435–53. https://doi.org/10.1038/s41571-021-00474-4.Full Text Link to Item
-
Ragoonanan, Dristhi, Sajad J. Khazal, Hisham Abdel-Azim, David McCall, Branko Cuglievan, Francesco Paolo Tambaro, Ali Haider Ahmad, et al. “Author Correction: Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.” Nat Rev Clin Oncol 18, no. 7 (July 2021): 468. https://doi.org/10.1038/s41571-021-00497-x.Full Text Link to Item
-
Bajwa, Rajinder P. S., Kimberly Taylor, Amanda Hoyt, Manmohan K. Kamboj, Joseph Stanek, Kris M. Mahadeo, Hawazen Alsaedi, et al. “Vitamin D has no impact on outcomes after HSCT in children-A retrospective study.” Pediatr Transplant 25, no. 4 (June 2021): e14008. https://doi.org/10.1111/petr.14008.Full Text Link to Item
-
Zhang, Hui, Anthony Pak-Yin Liu, Meenakshi Devidas, Shawn Hr Lee, Xueyuan Cao, Deqing Pei, Michael Borowitz, et al. “Association of GATA3 Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia.” J Natl Cancer Inst 113, no. 4 (April 6, 2021): 408–17. https://doi.org/10.1093/jnci/djaa138.Full Text Link to Item
-
Shah, Nirali N., Jennifer Schneiderman, Denison Kuruvilla, Deepa Bhojwani, Terry J. Fry, Paul L. Martin, Kirk R. Schultz, et al. “Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.” Pediatr Blood Cancer 68, no. 1 (January 2021): e28574. https://doi.org/10.1002/pbc.28574.Full Text Link to Item
-
Pasquini, Marcelo C., Zhen-Huan Hu, Kevin Curran, Theodore Laetsch, Frederick Locke, Rayne Rouce, Michael A. Pulsipher, et al. “Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.” Blood Adv 4, no. 21 (November 10, 2020): 5414–24. https://doi.org/10.1182/bloodadvances.2020003092.Full Text Link to Item
-
Heston, Sarah M., Rebecca R. Young, Hwanhee Hong, Ibukunoluwa C. Akinboyo, John S. Tanaka, Paul L. Martin, Richard Vinesett, et al. “Microbiology of Bloodstream Infections in Children After Hematopoietic Stem Cell Transplantation: A Single-Center Experience Over Two Decades (1997-2017).” Open Forum Infect Dis 7, no. 11 (November 2020): ofaa465. https://doi.org/10.1093/ofid/ofaa465.Full Text Link to Item
-
Tanaka, John S., Rebecca R. Young, Sarah M. Heston, Kirsten Jenkins, Lisa P. Spees, Anthony D. Sung, Kelly Corbet, et al. “Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.” Biol Blood Marrow Transplant 26, no. 11 (November 2020): 2053–60. https://doi.org/10.1016/j.bbmt.2020.07.011.Full Text Link to Item
-
Shah, Nirali N., Deepa Bhojwani, Keith August, André Baruchel, Yves Bertrand, Jessica Boklan, Luciano Dalla-Pozza, et al. “Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.” Pediatr Blood Cancer 67, no. 5 (May 2020): e28112. https://doi.org/10.1002/pbc.28112.Full Text Link to Item
-
Winick, Naomi, Paul L. Martin, Meenakshi Devidas, Jonathan Shuster, Michael J. Borowitz, W. Paul Bowman, Eric Larsen, et al. “Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905.” Leukemia 34, no. 4 (April 2020): 1006–16. https://doi.org/10.1038/s41375-019-0642-2.Full Text Link to Item
-
Akinboyo, Ibukunoluwa C., Rebecca R. Young, Lisa P. Spees, Sarah M. Heston, Michael J. Smith, Yeh-Chung Chang, Lauren E. McGill, et al. “Microbiology and Risk Factors for Hospital-Associated Bloodstream Infections Among Pediatric Hematopoietic Stem Cell Transplant Recipients.” Open Forum Infect Dis 7, no. 4 (April 2020): ofaa093. https://doi.org/10.1093/ofid/ofaa093.Full Text Open Access Copy Link to Item
-
Kelly, Matthew S., Doyle V. Ward, Christopher J. Severyn, Mehreen Arshad, Sarah M. Heston, Kirsten Jenkins, Paul L. Martin, et al. “Gut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation Recipients.” Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 25, no. 11 (November 2019): 2274–80. https://doi.org/10.1016/j.bbmt.2019.07.019.Full Text
-
Li, Lang, Tammy Sajdyk, Ellen M. L. Smith, Chien Wei Chang, Claire Li, Richard H. Ho, Raymond Hutchinson, et al. “Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.” Clin Pharmacol Ther 105, no. 6 (June 2019): 1421–28. https://doi.org/10.1002/cpt.1324.Full Text Link to Item
-
Parikh, Suhag H., Rebecca D. Pentz, Ann Haight, Mehdi Adeli, Paul L. Martin, Timothy A. Driscoll, Kristin Page, Joanne Kurtzberg, Vinod K. Prasad, and Raymond C. Barfield. “Ethical considerations of using a single minor donor for three bone marrow harvests for three HLA-matched siblings with primary immunodeficiency.” Pediatr Blood Cancer 66, no. 4 (April 2019): e27602. https://doi.org/10.1002/pbc.27602.Full Text Open Access Copy Link to Item
-
Spees, Lisa P., Paul L. Martin, Joanne Kurtzberg, Andre Stokhuyzen, Lauren McGill, Vinod K. Prasad, Timothy A. Driscoll, et al. “Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014).” Biol Blood Marrow Transplant 25, no. 4 (April 2019): 756–63. https://doi.org/10.1016/j.bbmt.2018.11.018.Full Text Open Access Copy Link to Item
-
Qian, Maoxiang, Heng Xu, Virginia Perez-Andreu, Kathryn G. Roberts, Hui Zhang, Wenjian Yang, Shouyue Zhang, et al. “Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics.” Blood 133, no. 7 (February 14, 2019): 724–29. https://doi.org/10.1182/blood-2018-07-862946.Full Text Link to Item
-
Lund, Troy C., Kwang Woo Ahn, Heather R. Tecca, Megan V. Hilgers, Hisham Abdel-Azim, Allistair Abraham, Miguel Angel Diaz, et al. “Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia.” Biol Blood Marrow Transplant 25, no. 2 (February 2019): 301–6. https://doi.org/10.1016/j.bbmt.2018.09.016.Full Text Link to Item
-
Mahadeo, Kris M., Sajad J. Khazal, Hisham Abdel-Azim, Julie C. Fitzgerald, Agne Taraseviciute, Catherine M. Bollard, Priti Tewari, et al. “Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.” Nat Rev Clin Oncol 16, no. 1 (January 2019): 45–63. https://doi.org/10.1038/s41571-018-0075-2.Full Text Link to Item
-
Huang, Sihong, Paul Martin, and M Jay Campbell. “Coronary artery occlusion secondary to graft versus host disease after bone marrow transplant in a 21-year-old.” Cardiol Young 28, no. 12 (December 2018): 1484–86. https://doi.org/10.1017/S1047951118001592.Full Text Link to Item
-
Duncan, Christine N., Ruta Brazauskas, Jiaxing Huang, Bronwen E. Shaw, Navneet S. Majhail, Bipin N. Savani, Mary E. D. Flowers, et al. “Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.” Bone Marrow Transplant 53, no. 10 (October 2018): 1278–87. https://doi.org/10.1038/s41409-018-0155-z.Full Text Link to Item
-
Jacobsohn, David A., Michael R. Loken, Mingwei Fei, Alexia Adams, Lisa Eidenschink Brodersen, Brent R. Logan, Kwang Woo Ahn, et al. “Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression.” Biol Blood Marrow Transplant 24, no. 10 (October 2018): 2040–46. https://doi.org/10.1016/j.bbmt.2018.06.010.Full Text Link to Item
-
Kelly, Matthew S., Lisa Spees, Richard Vinesett, Andre Stokhuyzen, Lauren McGill, Alan D. Proia, Kirsten Jenkins, Mehreen Arshad, Patrick C. Seed, and Paul L. Martin. “Utility of Autopsy among Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: One Last Chance to Learn?” Biol Blood Marrow Transplant 24, no. 9 (September 2018): 1861–65. https://doi.org/10.1016/j.bbmt.2018.05.030.Full Text Open Access Copy Link to Item
-
Qian, Maoxiang, Xueyuan Cao, Meenakshi Devidas, Wenjian Yang, Cheng Cheng, Yunfeng Dai, Andrew Carroll, et al. “TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.” J Clin Oncol 36, no. 6 (February 20, 2018): 591–99. https://doi.org/10.1200/JCO.2017.75.5215.Full Text Link to Item
-
Maude, Shannon L., Theodore W. Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, et al. “Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.” N Engl J Med 378, no. 5 (February 1, 2018): 439–48. https://doi.org/10.1056/NEJMoa1709866.Full Text Link to Item
-
Patel, Sachit A., Heather A. Allewelt, Jesse D. Troy, Paul L. Martin, Timothy A. Driscoll, Vinod K. Prasad, Joanne Kurtzberg, Kristin M. Page, and Suhag H. Parikh. “Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.” Biol Blood Marrow Transplant 23, no. 10 (October 2017): 1722–28. https://doi.org/10.1016/j.bbmt.2017.06.013.Full Text Open Access Copy Link to Item
-
Patel, S. A., H. A. allewelt, J. D. Troy, P. L. Martin, T. A. Driscoll, V. K. Prasad, J. Kurtzberg, K. M. Page, and S. H. Parikh. “Durable Chimerism and Long-Term Survival Following Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: a Single Center Experience.” Biology of Blood and Marrow Transplantation, June 19, 2017. https://doi.org/10.1016/j.bbmt.2017.06.010.Full Text Open Access Copy Link to Item
-
Sayour, Elias J., Talal Mousallem, David Van Mater, Endi Wang, Paul Martin, Rebecca H. Buckley, and Raymond C. Barfield. “Bone marrow transplantation for CVID-like humoral immune deficiency associated with red cell aplasia.” Pediatr Blood Cancer 63, no. 10 (October 2016): 1856–59. https://doi.org/10.1002/pbc.26092.Full Text Link to Item
-
Allewelt, Heather, Jill El-Khorazaty, Adam Mendizabal, Mahsa Taskindoust, Paul L. Martin, Vinod Prasad, Kristin Page, Jean Sanders, and Joanne Kurtzberg. “Late Effects after Umbilical Cord Blood Transplantation in Very Young Children after Busulfan-Based, Myeloablative Conditioning.” Biol Blood Marrow Transplant 22, no. 9 (September 2016): 1627–35. https://doi.org/10.1016/j.bbmt.2016.05.024.Full Text Open Access Copy Link to Item
-
Liu, Chengcheng, Wenjian Yang, Meenakshi Devidas, Cheng Cheng, Deqing Pei, Colton Smith, William L. Carroll, et al. “Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.” J Clin Oncol 34, no. 18 (June 20, 2016): 2133–40. https://doi.org/10.1200/JCO.2015.64.5812.Full Text Link to Item
-
Richardson, Paul G., Marcie L. Riches, Nancy A. Kernan, Joel A. Brochstein, Shin Mineishi, Amanda M. Termuhlen, Sally Arai, et al. “Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.” Blood 127, no. 13 (March 31, 2016): 1656–65. https://doi.org/10.1182/blood-2015-10-676924.Full Text Link to Item
-
Wild, Daniel, Anthony D. Sung, Diana Cardona, Constance Cirricione, Keith Sullivan, Claire Detweiler, Michael Shealy, et al. “The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review.” Dig Dis Sci 61, no. 3 (March 2016): 806–13. https://doi.org/10.1007/s10620-015-3938-8.Full Text Link to Item
-
Allewelt, Heather, Paul L. Martin, Paul Szabolcs, Nelson Chao, Rebecca Buckley, and Suhag Parikh. “Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.” Pediatr Blood Cancer 62, no. 12 (December 2015): 2216–22. https://doi.org/10.1002/pbc.25711.Full Text Link to Item
-
Moriyama, Takaya, Monika L. Metzger, Gang Wu, Rina Nishii, Maoxiang Qian, Meenakshi Devidas, Wenjian Yang, et al. “Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.” Lancet Oncol 16, no. 16 (December 2015): 1659–66. https://doi.org/10.1016/S1470-2045(15)00369-1.Full Text Link to Item
-
Mahadeo, Kris M., Priti Tewari, Suhag H. Parikh, Timothy A. Driscoll, Kristin Page, Paul L. Martin, Joanne Kurtzberg, and Vinod K. Prasad. “Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation.” Pediatr Transplant 19, no. 7 (November 2015): 753–57. https://doi.org/10.1111/petr.12577.Full Text Open Access Copy Link to Item
-
Yasuda, Eriko, William Mackenzie, Kristen Ruhnke, Tsutomu Shimada, Robert W. Mason, Jozef Zustin, Paul L. Martin, et al. “Molecular Genetics and Metabolism Report Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements.” Mol Genet Metab Rep 2 (March 2015): 65–76. https://doi.org/10.1016/j.ymgmr.2014.12.006.Full Text Link to Item
-
Parikh, Suhag H., Adam Mendizabal, Cara L. Benjamin, Krishna V. Komanduri, Jeyaraj Antony, Aleksandra Petrovic, Gregory Hale, et al. “A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.” Biol Blood Marrow Transplant 20, no. 3 (March 2014): 326–36. https://doi.org/10.1016/j.bbmt.2013.11.021.Full Text Open Access Copy Link to Item
-
McLaughlin, Colleen A., Marilyn J. Hockenberry, Joanne Kurtzberg, Rémi Hueckel, Paul L. Martin, and Sharron L. Docherty. “Standardization of health care provider competencies for intrathecal access procedures.” J Pediatr Oncol Nurs 31, no. 6 (2014): 304–16. https://doi.org/10.1177/1043454214543019.Full Text Open Access Copy Link to Item
-
Parikh, S. H., A. Mendizabal, C. L. Benjamin, K. V. Komanduri, J. Antony, A. Petrovic, G. Hale, et al. “A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.” Biology of Blood and Marrow Transplantation 20, no. 3 (2014): 326–36.Open Access Copy
-
Xu, Heng, Wenjian Yang, Virginia Perez-Andreu, Meenakshi Devidas, Yiping Fan, Cheng Cheng, Deqing Pei, et al. “Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.” J Natl Cancer Inst 105, no. 10 (May 15, 2013): 733–42. https://doi.org/10.1093/jnci/djt042.Full Text Link to Item
-
Boelens, Jaap Jan, Mieke Aldenhoven, Duncan Purtill, Annalisa Ruggeri, Todd Defor, Robert Wynn, Ed Wraith, et al. “Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.” Blood 121, no. 19 (May 9, 2013): 3981–87. https://doi.org/10.1182/blood-2012-09-455238.Full Text Open Access Copy Link to Item
-
Ramsey, Laura B., John C. Panetta, Colton Smith, Wenjian Yang, Yiping Fan, Naomi J. Winick, Paul L. Martin, et al. “Genome-wide study of methotrexate clearance replicates SLCO1B1.” Blood 121, no. 6 (February 7, 2013): 898–904. https://doi.org/10.1182/blood-2012-08-452839.Full Text Link to Item
-
Yang, Jun J., Cheng Cheng, Meenakshi Devidas, Xueyuan Cao, Dario Campana, Wenjian Yang, Yiping Fan, et al. “Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.” Blood 120, no. 20 (November 15, 2012): 4197–4204. https://doi.org/10.1182/blood-2012-07-440107.Full Text Link to Item
-
Tewari, Priti, Paul L. Martin, Adam Mendizabal, Suhag H. Parikh, Kristin M. Page, Timothy A. Driscoll, Harry L. Malech, Joanne Kurtzberg, and Vinod K. Prasad. “Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.” Biol Blood Marrow Transplant 18, no. 9 (September 2012): 1368–77. https://doi.org/10.1016/j.bbmt.2012.02.002.Full Text Open Access Copy Link to Item
-
Corbacioglu, Selim, Nancy Kernan, Leslie Lehmann, Joel Brochstein, Carolyn Revta, Stephan Grupp, Paul Martin, and Paul G. Richardson. “Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.” Expert Rev Hematol 5, no. 3 (June 2012): 291–302. https://doi.org/10.1586/ehm.12.18.Full Text Link to Item
-
Doby, Elizabeth H., Daniel K. Benjamin, Anne J. Blaschke, Robert M. Ward, Andrew T. Pavia, Paul L. Martin, Timothy A. Driscoll, Michael Cohen-Wolkowiez, and Cassandra Moran. “Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.” Pediatr Infect Dis J 31, no. 6 (June 2012): 632–35. https://doi.org/10.1097/INF.0b013e31824acc33.Full Text Link to Item
-
Xu, Heng, Cheng Cheng, Meenakshi Devidas, Deqing Pei, Yiping Fan, Wenjian Yang, Geoff Neale, et al. “ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.” J Clin Oncol 30, no. 7 (March 1, 2012): 751–57. https://doi.org/10.1200/JCO.2011.38.0345.Full Text Link to Item
-
Hueckel, Rémi M., Jane M. Mericle, Karen Frush, Paul L. Martin, and Mary T. Champagne. “Implementation of condition help: family teaching and evaluation of family understanding.” J Nurs Care Qual 27, no. 2 (2012): 176–81. https://doi.org/10.1097/NCQ.0b013e318235bdec.Full Text Link to Item
-
Martin, Paul L., Joanne Kurtzberg, and Brett Hesse. “Umbilical cord blood: a guide for primary care physicians.” Am Fam Physician 84, no. 6 (September 15, 2011): 661–66.Open Access Copy Link to Item
-
Driscoll, T. A., P. L. Martin, J. Moffet, M. Daniel, K. Page, S. Parikh, V. Prasad, P. Szabolcs, and J. Kurtzberg. “Allogeneic transplantation for patients with high-risk or refractory neuroblastoma.” J Clin Oncol 29, no. 15_suppl (May 20, 2011): 9552.Link to Item
-
Driscoll, T. A., P. L. Martin, J. Moffet, M. Daniel, K. Page, S. Parikh, V. Prasad, P. Szabolcs, and J. Kurtzberg. “Allogeneic transplantation for patients with high-risk or refractory neuroblastoma.” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 9552–9552. https://doi.org/10.1200/jco.2011.29.15_suppl.9552.Full Text
-
Yang, Jun J., Cheng Cheng, Meenakshi Devidas, Xueyuan Cao, Yiping Fan, Dario Campana, Wenjian Yang, et al. “Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.” Nat Genet 43, no. 3 (March 2011): 237–41. https://doi.org/10.1038/ng.763.Full Text Link to Item
-
Maloney, Kelly W., William L. Carroll, Andrew J. Carroll, Meenakshi Devidas, Michael J. Borowitz, Paul L. Martin, Jeanette Pullen, et al. “Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.” Blood 116, no. 7 (August 19, 2010): 1045–50. https://doi.org/10.1182/blood-2009-07-235291.Full Text Link to Item
-
Richardson, Paul G., Robert J. Soiffer, Joseph H. Antin, Hajime Uno, Zhezhen Jin, Joanne Kurtzberg, Paul L. Martin, et al. “Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.” Biol Blood Marrow Transplant 16, no. 7 (July 2010): 1005–17. https://doi.org/10.1016/j.bbmt.2010.02.009.Full Text Open Access Copy Link to Item
-
Coppell, Jason A., Paul G. Richardson, Robert Soiffer, Paul L. Martin, Nancy A. Kernan, Allen Chen, Eva Guinan, et al. “Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.” Biol Blood Marrow Transplant 16, no. 2 (February 2010): 157–68. https://doi.org/10.1016/j.bbmt.2009.08.024.Full Text Link to Item
-
Parikh, Suhag H., Adam Mendizabal, Paul L. Martin, Vinod K. Prasad, Paul Szabolcs, Timothy A. Driscoll, and Joanne Kurtzberg. “Unrelated donor umbilical cord blood transplantation in pediatric myelodysplastic syndrome: a single-center experience.” Biol Blood Marrow Transplant 15, no. 8 (August 2009): 948–55. https://doi.org/10.1016/j.bbmt.2009.04.010.Full Text Link to Item
-
Cash, J. V., C. M. Sweezy, A. Browne-Topete, P. L. Martin, D. L. Georgas, and N. A. Larrier. “Easing the TBI Experience in the Pre-School Patient.” Biology of Blood and Marrow Transplantation 15, no. 2 (February 2009): 32–33. https://doi.org/10.1016/j.bbmt.2008.12.100.Full Text
-
Sun, J. M., T. Driscoll, V. K. Prasad, S. Parikh, P. Szabolcs, J. Kurtzberg, and P. L. Martin. “Unrelated Umbilical Cord Blood Transplantation is an Effective Therapy for Wiskott-Aldrich Syndrome.” Biology of Blood and Marrow Transplantation 15, no. 2 (February 2009): 76–76. https://doi.org/10.1016/j.bbmt.2008.12.234.Full Text
-
Prasad, Vinod K., Adam Mendizabal, Suhag H. Parikh, Paul Szabolcs, Timothy A. Driscoll, Kristin Page, Sonali Lakshminarayanan, et al. “Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes.” Blood 112, no. 7 (October 1, 2008): 2979–89. https://doi.org/10.1182/blood-2008-03-140830.Full Text Link to Item
-
Page, Kristin M., Adam M. Mendizabal, Vinod K. Prasad, Paul L. Martin, Suhag Parikh, Susan Wood, Gregory D. Sempowski, Paul Szabolcs, and Joanne Kurtzberg. “Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.” Biol Blood Marrow Transplant 14, no. 10 (October 2008): 1108–17. https://doi.org/10.1016/j.bbmt.2008.07.006.Full Text Link to Item
-
Borowitz, Michael J., Meenakshi Devidas, Stephen P. Hunger, W Paul Bowman, Andrew J. Carroll, William L. Carroll, Stephen Linda, et al. “Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.” Blood 111, no. 12 (June 15, 2008): 5477–85. https://doi.org/10.1182/blood-2008-01-132837.Full Text Link to Item
-
Maloney, K., W. L. Carroll, A. Carroll, M. Devidas, S. P. Hunger, P. L. Martin, C. L. Willman, N. Winick, J. Whitlock, and B. M. Camitta. “Comparison of the biology of Down syndrome (DS) acute lymphoblastic leukemia (ALL) and non-DS ALL: Children's Oncology Group (COG) study P9900.” J Clin Oncol 26, no. 15_suppl (May 20, 2008): 10003.Link to Item
-
Maloney, K., W. L. Carroll, A. Carroll, M. Devidas, S. P. Hunger, P. L. Martin, C. L. Willman, N. Winick, J. Whitlock, and B. M. Camitta. “Comparison of the biology of Down syndrome (DS) acute lymphoblastic leukemia (ALL) and non-DS ALL: Children’s Oncology Group (COG) study P9900.” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 10003–10003. https://doi.org/10.1200/jco.2008.26.15_suppl.10003.Full Text
-
Davies, Stella M., Michael J. Borowitz, Gary L. Rosner, Kristin Ritz, Meenakshi Devidas, Naomi Winick, Paul L. Martin, et al. “Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.” Blood 111, no. 6 (March 15, 2008): 2984–90. https://doi.org/10.1182/blood-2007-09-114082.Full Text Link to Item
-
White, Matthew S., Paul L. Martin, and Thomas W. McLean. “Acute myelogenous leukemia associated with Ollier disease.” Pediatr Blood Cancer 50, no. 3 (March 2008): 645–46. https://doi.org/10.1002/pbc.21050.Full Text Link to Item
-
Parikh, Suhag H., Paul Szabolcs, Vinod K. Prasad, Sonali Lakshminarayanan, Paul L. Martin, Timothy A. Driscoll, and Joanne Kurtzberg. “Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation.” Pediatr Blood Cancer 49, no. 7 (December 2007): 982–84. https://doi.org/10.1002/pbc.21365.Full Text Link to Item
-
Chauvenet, Allen R., Paul L. Martin, Meenakshi Devidas, Stephen B. Linda, Beverly A. Bell, Joanne Kurtzberg, Jeanette Pullen, et al. “Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.” Blood 110, no. 4 (August 15, 2007): 1105–11. https://doi.org/10.1182/blood-2006-12-061689.Full Text Link to Item
-
Steinbach, William J., Rachel M. Addison, Lisa McLaughlin, Quincy Gerrald, Paul L. Martin, Timothy Driscoll, Christopher Bentsen, John R. Perfect, and Barbara D. Alexander. “Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients.” Pediatr Infect Dis J 26, no. 7 (July 2007): 558–64. https://doi.org/10.1097/INF.0b013e3180616cbb.Full Text Link to Item
-
Beam, Donald, Michele D. Poe, James M. Provenzale, Paul Szabolcs, Paul L. Martin, Vinod Prasad, Suhag Parikh, et al. “Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.” Biol Blood Marrow Transplant 13, no. 6 (June 2007): 665–74. https://doi.org/10.1016/j.bbmt.2007.01.082.Full Text Link to Item
-
Lakshminarayanan, Sonali, Adam Mendizabal, Vinod Prasad, Suhag Parikh, Paul Szabolcs, Timothy Driscoll, Michelle Schweitzer, et al. “The Addition of Fludarabine to a Conventional Busulfan/Melphalan/Anti-Thymocyte Globulin (Flu/Bu/Mel/ATG) Preparative Regimen Increased Engraftment without Additional Toxicity.” Blood 108, no. 11 (November 16, 2006): 2944–2944. https://doi.org/10.1182/blood.v108.11.2944.2944.Full Text
-
Martin, Paul L. “To stop or not to stop: how much support should be provided to mechanically ventilated pediatric bone marrow and stem cell transplant patients?” Respir Care Clin N Am 12, no. 3 (September 2006): 403–19. https://doi.org/10.1016/j.rcc.2006.06.002.Full Text Link to Item
-
Martin, Paul L., Shelly L. Carter, Nancy A. Kernan, Indira Sahdev, Donna Wall, Daniel Pietryga, John E. Wagner, and Joanne Kurtzberg. “Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases.” Biol Blood Marrow Transplant 12, no. 2 (February 2006): 184–94. https://doi.org/10.1016/j.bbmt.2005.09.016.Full Text Link to Item
-
Borowitz, Michael J., D Jeanette Pullen, Naomi Winick, Paul L. Martin, W Paul Bowman, and Bruce Camitta. “Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.” Cytometry B Clin Cytom 68, no. 1 (November 2005): 18–24. https://doi.org/10.1002/cyto.b.20071.Full Text Link to Item
-
Quaranta, Brian P., Edward C. Halperin, Joanne Kurtzberg, Robert Clough, and Paul L. Martin. “The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation.” Cancer 101, no. 4 (August 15, 2004): 845–50. https://doi.org/10.1002/cncr.20413.Full Text Link to Item
-
Hall, Jennifer G., Paul L. Martin, Susan Wood, and Joanne Kurtzberg. “Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major.” J Pediatr Hematol Oncol 26, no. 6 (June 2004): 382–85. https://doi.org/10.1097/00043426-200406000-00010.Full Text Link to Item
-
Staba, Susan L., Maria L. Escolar, Michele Poe, Young Kim, Paul L. Martin, Paul Szabolcs, June Allison-Thacker, et al. “Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.” N Engl J Med 350, no. 19 (May 6, 2004): 1960–69. https://doi.org/10.1056/NEJMoa032613.Full Text Link to Item
-
Steinbach, W. J., W. A. Schell, J. L. Miller, J. R. Perfect, and P. L. Martin. “Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.” J Infect 48, no. 1 (January 2004): 112–16. https://doi.org/10.1016/s0163-4453(03)00134-8.Full Text Link to Item
-
Jaroscak, Jennifer, Kristin Goltry, Alan Smith, Barbara Waters-Pick, Paul L. Martin, Timothy A. Driscoll, Richard Howrey, et al. “Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System.” Blood 101, no. 12 (June 15, 2003): 5061–67. https://doi.org/10.1182/blood-2001-12-0290.Full Text Link to Item
-
Gururangan, Sridharan, Colleen McLaughlin, Jennifer Quinn, Jeremy Rich, David Reardon, Edward C. Halperin, James Herndon, et al. “High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas.” J Clin Oncol 21, no. 11 (June 1, 2003): 2187–91. https://doi.org/10.1200/JCO.2003.10.096.Full Text Link to Item
-
Hagen, Scott A., Damian M. Craig, Paul L. Martin, Devon D. Plumer, Michael A. Gentile, Scott R. Schulman, and Ira M. Cheifetz. “Mechanically ventilated pediatric stem cell transplant recipients: effect of cord blood transplant and organ dysfunction on outcome.” Pediatr Crit Care Med 4, no. 2 (April 2003): 206–13. https://doi.org/10.1097/01.PCC.0000043293.83440.79.Full Text Link to Item
-
Whyte, Michael P., Joanne Kurtzberg, William H. McAlister, Steven Mumm, Michelle N. Podgornik, Stephen P. Coburn, Lawrence M. Ryan, et al. “Marrow cell transplantation for infantile hypophosphatasia.” J Bone Miner Res 18, no. 4 (April 2003): 624–36. https://doi.org/10.1359/jbmr.2003.18.4.624.Full Text Link to Item
-
Richardson, Paul G., Carol Murakami, Zhezhen Jin, Diane Warren, Parisa Momtaz, Deborah Hoppensteadt, Anthony D. Elias, et al. “Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome.” Blood 100, no. 13 (December 15, 2002): 4337–43. https://doi.org/10.1182/blood-2002-04-1216.Full Text Link to Item
-
Benjamin, Daniel Kelly, William C. Miller, Sherry Bayliff, Lisa Martel, Kenneth A. Alexander, and Paul Langlie Martin. “Infections diagnosed in the first year after pediatric stem cell transplantation.” Pediatr Infect Dis J 21, no. 3 (March 2002): 227–34. https://doi.org/10.1097/00006454-200203000-00013.Full Text Link to Item
-
Hagen, S. A., D. Plumer, M. A. Gentile, D. M. Craig, J. N. Meliones, P. L. Martin, and I. M. Cheifetz. “Survival of pediatric bone marrow transplant recipients requiring mechanical ventilation and the influence of unrelated umbilical cord blood transplant on outcome.” Critical Care Medicine 29, no. 12 (December 1, 2001): A131–A131.Link to Item
-
Richardson, P. G., D. L. Warren, P. Momtaz, R. Soiffer, J. H. Antin, T. Spitzer, D. Avigan, et al. “Multi-institutional phase II, randomized dose finding study of defibrotide (DF) in patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Promising response rate without significant toxicity in a high risk population.” Blood 98, no. 11 (November 16, 2001): 853A-853A.Link to Item
-
Staba, S. L., P. L. Martin, G. H. Ciocci, J. Allison-Thacker, and J. Kurtzberg. “Correction of Hurler Syndrome with unrelated umbilical cord blood transplantation.” Blood 98, no. 11 (November 16, 2001): 667A-667A.Link to Item
-
Wainwright, M. S., P. L. Martin, R. P. Morse, M. Lacaze, J. M. Provenzale, R. E. Coleman, M. A. Morgan, et al. “Human herpesvirus 6 limbic encephalitis after stem cell transplantation.” Ann Neurol 50, no. 5 (November 2001): 612–19. https://doi.org/10.1002/ana.1251.Full Text Link to Item
-
Barker, J. N., P. L. Martin, J. E. Coad, T. DeFor, M. E. Trigg, J. Kurtzberg, D. J. Weisdorf, and J. Wagner. “Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.” Biol Blood Marrow Transplant 7, no. 7 (2001): 395–99. https://doi.org/10.1053/bbmt.2001.v7.pm11529490.Full Text Link to Item
-
Safford, S. D., K. M. Safford, P. Martin, H. Rice, J. Kurtzberg, and M. A. Skinner. “Management of cholelithiasis in pediatric patients who undergo bone marrow transplantation.” J Pediatr Surg 36, no. 1 (January 2001): 86–90. https://doi.org/10.1053/jpsu.2001.20016.Full Text Link to Item
-
Howrey, R. P., P. L. Martin, T. Driscoll, P. Szabolcs, T. Kelly, E. J. Shpall, S. I. Bearman, et al. “Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.” Bone Marrow Transplant 26, no. 11 (December 2000): 1251–54. https://doi.org/10.1038/sj.bmt.1702697.Full Text Link to Item
-
Kurtzberg, J., P. L. Martin, and P. M. Szabolcs. “Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank.” Blood 96, no. 11 PART I (December 1, 2000).
-
Kurtzberg, J., P. Szabolcs, R. P. Howrey, T. A. Driscoll, and P. L. Martin. “High dose chemotherapy followed by transplantation of unrelated, banked, umbilical cord blood provides curative therapy for young pediatric patients with familial erythrophagocytic lymphohistiocytosis fed.” Blood 96, no. 11 PART II (December 1, 2000).
-
Martin, P. L., and M. Lacaze. “Unrelated umbilical cord blood transplant for osteopetrosis.” Blood 96, no. 11 PART I (December 1, 2000).
-
Barker, J. N., P. L. Martin, T. Defor, D. J. Weisdorf, J. Kurtzberg, and J. E. Wagner. “Low incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorders (EBV-PTLD) in 263 unrelated donor umbilical cord blood transplant recipients.” Blood 96, no. 11 (November 16, 2000): 206A-206A.Link to Item
-
Kurtzberg, J., P. L. Martin, P. M. Szabolcs, R. P. Howrey, T. A. Driscoll, C. E. Stevens, and P. Rubinstein. “Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank.” Blood 96, no. 11 (November 16, 2000): 206A-206A.Link to Item
-
Kurtzberg, J., P. Szabolcs, R. P. Howrey, T. A. Driscoll, and P. L. Martin. “High dose chemotherapy followed by transplantation of unrelated, banked, umbilical cord blood provides curative therapy for young pediatric patients with familial erythrophagocytic lymphohistiocytosis (FEL).” Blood 96, no. 11 (November 16, 2000): 362B-362B.Link to Item
-
Martin, P. L., M. Lacaze, T. A. Driscoll, P. Szaboles, J. Kurtzberg, J. Wiley, P. Rubinstein, and R. P. Howrey. “Unrelated umbilical cord blood transplant for osteopetrosis.” Blood 96, no. 11 (November 16, 2000): 207A-207A.Link to Item
-
Klock, B., T. Pham, L. S. Smith, S. Beris, F. M. Lobo, P. L. Martin, J. Rappeport, and R. L. Fuleihan. “When you hear hoof beats...do not forget the zebras.” Curr Opin Pediatr 12, no. 2 (April 2000): 172–77. https://doi.org/10.1097/00008480-200004000-00016.Full Text Link to Item
-
Kurtzberg, J., P. Martin, N. Chao, C. Stevens, and P. Rubinstein. “Unrelated placental blood in marrow transplantation.” Stem Cells 18, no. 2 (2000): 153–54. https://doi.org/10.1634/stemcells.18-2-153.Full Text Link to Item
-
Kurtzberg, J., J. Jaroscak, P. L. Martin, T. Driscoll, B. Waters-Pick, J. Douville, R. Howrey, K. L. Goltry, and A. K. Smith. “Augmentation of umbilical cord blood (UCB) transplantation with ex vivo expaned cells, a phase I trial using the replicell system.” Blood 94, no. 10 (November 15, 1999): 571A-571A.Link to Item
-
Kurtzberg, J., P. Szabolcs, T. Driscoll, R. Howrey, B. Waters-Pick, and P. L. Martin. “Transplantation of a patient with congenital neutropenia and invasive fungal disease with unrelated umbilical cord blood using paternal G-CSF mobilized, irradiated granulocyte support.” Blood 94, no. 10 (November 15, 1999): 368B-369B.Link to Item
-
Graham, M. L., E. Katsanis, T. W. Shapiro, J. J. Hutter, P. L. Martin, and J. Kurtzberg. “Busulfan and melphalan as preparative therapy for BMT in childhood leukemias.” Blood 92, no. 10 (November 15, 1998): 128A-128A.Link to Item
-
Howrey, R. P., P. L. Martin, G. Ciocci, T. A. Driscoll, M. Frey, R. H. Buckley, W. H. Hickling, et al. “Unrelated cord blood transplantation for correction of genetic diseases.” Blood 92, no. 10 (November 15, 1998): 291A-291A.Link to Item
-
Jaroscak, J., P. L. Martin, B. Waters-Pick, R. D. Armstrong, T. Driscoll, R. P. Howrey, S. Castellino, et al. “A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells.” Blood 92, no. 10 (November 15, 1998): 646A-646A.Link to Item
-
Kurtzberg, J., C. Carrier, P. L. Martin, C. E. Stevens, R. P. Howrey, T. A. Driscoll, N. Reismoen, and P. Rubinstein. “Transient engraftment of maternal T-cells in recipients of unrelated cord blood transplants.” Blood 92, no. 10 (November 15, 1998): 652A-653A.Link to Item
-
Martin, P. L., R. Howrey, T. Driscoll, B. Frothingham, W. Owen, P. Kelly, Y. Lee, N. Hamerschlak, and J. Kurtzberg. “Transplantation of related, haplo-identical umbilical cord blood in pediatric patients with genetic hematological diseases.” Blood 92, no. 10 (November 15, 1998): 358B-358B.Link to Item
-
Graham, M. L., B. L. Asselin, J. E. Herndon, J. R. Casey, S. Chaffee, G. H. Ciocci, C. W. Daeschner, et al. “Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemia.” Bone Marrow Transplant 21, no. 9 (May 1998): 879–85. https://doi.org/10.1038/sj.bmt.1701223.Full Text Link to Item
-
Laughlin, M. J., D. A. Rizzieri, C. A. Smith, J. O. Moore, S. Lilly, D. McGaughey, P. Martin, et al. “Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.” Leuk Res 22, no. 3 (March 1998): 215–19. https://doi.org/10.1016/s0145-2126(97)00171-9.Full Text Link to Item
-
Martin, P. L., J. Jaroscak, N. Hamerschlak, and J. Kurtzberg. “Correction of beta thalassemia major with umbilical cord blood transplantation from a related haploidentical donor.” Blood 90, no. 10 (November 15, 1997): 4536–4536.Link to Item
-
Martin, P. L., J. Thompson, G. Gottesman, J. Reid, M. P. Whyte, C. Miller, and J. Kurtzberg. “Marked radiographic improvement in infantile hypophosphatasia with T-depleted bone marrow transplantation from a related haploidentical donor.” Blood 90, no. 10 (November 15, 1997): 4537–4537.Link to Item
-
Martin, P. L., A. T. Look, S. Schnell, M. B. Harris, J. Pullen, J. J. Shuster, A. J. Carroll, M. J. Pettenati, and P. N. Rao. “Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group study.” J Pediatr Hematol Oncol 18, no. 2 (May 1996): 113–21. https://doi.org/10.1097/00043426-199605000-00004.Full Text Link to Item
-
Kilpatrick, S. E., L. A. Teot, K. R. Geisinger, P. L. Martin, D. K. Shumate, N. Zbieranski, G. B. Russell, and C. D. Fletcher. “Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis.” Cancer 74, no. 12 (December 15, 1994): 3227–33. https://doi.org/10.1002/1097-0142(19941215)74:12<3227::aid-cncr2820741223>3.0.co;2-x.Full Text Link to Item
-
Martin, P. L., and J. M. Rappeport. “Bone marrow transplantation in the perinatal period.” Semin Perinatol 14, no. 5 (October 1990): 416–22.Link to Item
-
Bieker, J. J., P. L. Martin, and R. G. Roeder. “Formation of a rate-limiting intermediate in 5S RNA gene transcription.” Cell 40, no. 1 (January 1985): 119–27. https://doi.org/10.1016/0092-8674(85)90315-0.Full Text Link to Item
-
Lassar, A. B., P. L. Martin, and R. G. Roeder. “Transcription of class III genes: formation of preinitiation complexes.” Science 222, no. 4625 (November 18, 1983): 740–48. https://doi.org/10.1126/science.6356356.Full Text Link to Item
-
Dignam, J. D., P. L. Martin, B. S. Shastry, and R. G. Roeder. “Eukaryotic gene transcription with purified components.” Methods Enzymol 101 (1983): 582–98. https://doi.org/10.1016/0076-6879(83)01039-3.Full Text Link to Item
-
-
Conference Papers
-
Escherich, Carolin, Wenan Chen, Satoshi Miyamoto, Yui Namikawa, Wenjian Yang, David T. Teachey, Zhenhua Li, et al. “Rare Deleterious TCF3 Germline Variants and Predisposition to Acute Lymphoblastic Leukemia in Children.” In Blood, 140:990–91. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-158556.Full Text
-
John, Samuel, Michael A. Pulsipher, Amy Moskop, Zhen-Huan Hu, Christine L. Phillips, Erin Marie Hall, Steven P. Margossian, et al. “Real-World Outcomes for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (ALL) Treated with Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry.” In Blood, 138:428–428. American Society of Hematology, 2021. https://doi.org/10.1182/blood-2021-146393.Full Text
-
Robles, Joanna M., Jesse D. Troy, Kristin M. Schroeder, Paul L. Martin, and Thomas W. LeBlanc. “The Effect of Limited-English Proficiency on Hematopoietic Stem Cell Transplantation Outcomes: A Retrospective Cohort Study of Hispanic Pediatric Transplant Patients at a Single Institution.” In Biology of Blood and Marrow Transplantation, 26:S195–96. ELSEVIER SCIENCE INC, 2020.Link to Item
-
Tanaka, John, Rebecca Young, Lisa Spees, Kirsten Jenkins, Anthony D. Sung, Paul L. Martin, Sarah Heston, et al. “Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.” In Blood, 134:1992–1992. American Society of Hematology, 2019. https://doi.org/10.1182/blood-2019-125080.Full Text
-
Bajwa, Rajinder P. S., Kimberly Taylor, Amanda R. Hoyt, Manmohan Kamboj, Jeffery J. Auletta, Joseph Stanek, Kris Michael Mahadeo, et al. “Effects of Vitamin D Levels on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children.” In Biology of Blood and Marrow Transplantation, Vol. 25, 2019.Link to Item
-
Brondon, Jennifer E., Kristin Page, Veronika Polishchuk, Timothy A. Driscoll, Suhag Parikh, Paul L. Martin, Joanne Kurtzberg, and Vinod K. Prasad. “Outcomes of Umbilical Cord Blood Transplantation in Children with Batten Disease.” In Biology of Blood and Marrow Transplantation, Vol. 25, 2019.Link to Item
-
Grupp, Stephan A., Shannon L. Maude, Susana Rives, Andre Baruchel, Michael Boyer, Henrique Bittencourt, Peter Bader, et al. “Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia: Updated Analysis of the ELIANA Clinical Trial.” In Biology of Blood and Marrow Transplantation, Vol. 25, 2019.Link to Item
-
Grupp, Stephan A., Shannon L. Maude, Susana Rives, Andre Baruchel, Michael W. Boyer, Henrique Bittencourt, Peter Bader, et al. “Updated Analysis of the Efficacy and Safety of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed/Refractory (r/r) Acute Lymphoblastic Leukemia.” In Blood, 132:895–895. American Society of Hematology, 2018. https://doi.org/10.1182/blood-2018-99-112599.Full Text
-
Churchman, Michelle L., Maoxiang Qian, Geertruy Te Kronnie, Ranran Zhang, Wenjian Yang, Hui Zhang, Tobia Lana, et al. “Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.” In Cancer Cell, 33:937-948.e8, 2018. https://doi.org/10.1016/j.ccell.2018.03.021.Full Text Link to Item
-
Parikh, Suhag, Joel A. Brochstein, Stephen Wease, Paul L. Martin, Mitchell E. Horwitz, Aurelie Schwarzbach, and Joanne Kurtzberg. “A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD.” In Biology of Blood and Marrow Transplantation, 24:S157–58. ELSEVIER SCIENCE INC, 2018.Link to Item
-
Buechner, Jochen, Stephan A. Grupp, Shannon L. Maude, Michael Boyer, Henrique Bittencourt, Theodore W. Laetsch, Peter Bader, et al. “Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis.” In Clinical Lymphoma Myeloma and Leukemia, 17:S263–64. Elsevier BV, 2017. https://doi.org/10.1016/j.clml.2017.07.030.Full Text
-
Buechner, J., S. A. Grupp, S. L. Maude, M. Boyer, H. Bittencourt, T. W. Laetsch, P. Bader, et al. “GLOBAL REGISTRATION TRIAL OF EFFICACY AND SAFETY OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): UPDATE TO THE INTERIM ANALYSIS.” In Haematologica, 102:178–178. FERRATA STORTI FOUNDATION, 2017.Link to Item
-
Maude, S. L., S. A. Grupp, M. A. Pulsipher, S. Rives, G. D. Myers, M. R. Verneris, J. Buechner, et al. “ANALYSIS OF SAFETY DATA FROM 2 MULTICENTER TRIALS OF CTL019 IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL).” In Haematologica, 102:197–98. FERRATA STORTI FOUNDATION, 2017.Link to Item
-
Parikh, Suhag, Joel Brochstein, Paul L. Martin, Mitchell E. Horwitz, Einat Galamidi, Iddo Peleg, Uri Goshen, et al. “Successful Engraftment of Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord (R) (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and an Unmanipulated UCB Unit after Myeloablative Chemotherapy in Severe Sickle Cell Disease.” In Biology of Blood and Marrow Transplantation, 23:S150–51, 2017.Link to Item
-
Stafford, Lauren, Jesse D. Troy, Timothy A. Driscoll, Kristin Page, Suhag Parikh, Vinod K. Prasad, Joanne Kurtzberg, and Paul L. Martin. “Outcomes of Second Transplants for Patients with Hematological Malignancies Who Relapse after First Transplant: A Retrospective Analysis of a Single Institution Experience.” In Biology of Blood and Marrow Transplantation, 23:S152–S152, 2017.Link to Item
-
Grupp, Stephan A., Theodore W. Laetsch, Jochen Buechner, Henrique Bittencourt, Shannon L. Maude, Michael R. Verneris, Gary D. Myers, et al. “Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL).” In Blood, 128:221–221. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.221.221.Full Text
-
Parikh, Suhag H., Joel Brochstein, Paul L. Martin, Mitchell E. Horwitz, Einat Galamidi, Iddo Peleg, Uri Goshen, et al. “Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord® (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease.” In Blood, 128:3651–3651. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.3651.3651.Full Text
-
Allewelt, Heather B., Sachit Patel, Vinod K. Prasad, Joanne Kurtzberg, Timothy A. Driscoll, Paul L. Martin, Kristin Page, and Suhag Parikh. “Umbilical Cord Blood Transplantation for Cartilage Hair Hypoplasia: A Single Center Experience Demonstrates Excellent Outcomes Using Myeloablative Preparative Regimens.” In Biology of Blood and Marrow Transplantation, 22:S235–S235. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.646.Full Text
-
Martin, Paul L., Gideon Steinbach, Allen R. Chen, Amrita Krishnan, Nancy A. Kernan, David E. Avigan, Thomas R. Spitzer, and Paul G. Richardson. “Pooled Dose Response Analysis of Defibrotide in >1600 Patients for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.” In Biology of Blood and Marrow Transplantation, 22:S337–38. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.822.Full Text
-
Patel, Sachit, Heather B. Allewelt, Paul L. Martin, Kristin Page, Timothy A. Driscoll, Vinod K. Prasad, Joanne Kurtzberg, and Suhag Parikh. “Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis.” In Biology of Blood and Marrow Transplantation, 22:S257–S257. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.686.Full Text
-
Richardson, Paul G., Nancy A. Kernan, Joel A. Brochstein, Shin Mineishi, Sally Arai, Stephan A. Grupp, Eva Guinan, et al. “Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial.” In Biology of Blood and Marrow Transplantation, 22:S25–S25. Elsevier BV, 2016. https://doi.org/10.1016/j.bbmt.2015.11.306.Full Text
-
Richardson, Paul G., Marcie Riches, Nancy A. Kernan, Joel A. Brochstein, Shin Mineishi, Amanda M. Termuhlen, Sally Arai, et al. “Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with Multi-Organ Dysfunction: Final Results from a Pivotal, Historically Controlled, Phase 3 Trial.” In Blood, Vol. 126. AMER SOC HEMATOLOGY, 2015.Link to Item
-
Satwani, P., Z. Jin, P. L. Martin, M. Bhatia, J. H. Garvin, D. George, S. Chaudhury, et al. “Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma.” In Leukemia, 29:448–55, 2015. https://doi.org/10.1038/leu.2014.194.Full Text Link to Item
-
Ciocci, Gil, Lauren Stafford, Timothy A. Driscoll, Paul L. Martin, and Joanne Kurtzberg. “Hyperthyroidism As a Complication Following Myloablative Therapy and Stem Cell Transplantation for Childhood Diseases.” In Biology of Blood and Marrow Transplantation, 21:S214–15. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.329.Full Text
-
McFarren, Alicia, P Brian Smith, Kristin Page, Heather B. Allewelt, Suhag Parikh, Timothy A. Driscoll, Paul L. Martin, Joanne Kurtzberg, and Vinod K. Prasad. “Outcomes of Second Unrelated Donor Cord Blood Transplants (UCBT) Performed in Children with Graft Failure of Autologous Recovery Following the First UCBT.” In Biology of Blood and Marrow Transplantation, 21:S37–38. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.030.Full Text
-
Richardson, Paul G., Nancy A. Kernan, Stephan A. Grupp, Paul L. Martin, Robert J. Soiffer, Richard Martin, Alison Hannah, and Kathleen F. Villa. “Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival.” In Biology of Blood and Marrow Transplantation, 21:S110–S110. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.138.Full Text
-
Richardson, Paul G., Nancy A. Kernan, Stephan A. Grupp, Paul L. Martin, Robert J. Soiffer, Richard Martin, Alison L. Hannah, and Kathleen F. Villa. “Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease: An Analysis of Clinical Benefit As Determined By Number Needed to Treat (NNT) to Achieve Complete Response and to Improve Survival.” In Blood, Vol. 124. AMER SOC HEMATOLOGY, 2014.Link to Item
-
Allewelt, Heather B., Paul L. Martin, Vinod K. Prasad, Kristin Page, and Joanne Kurtzberg. “Late Effects in Infants and Young Children Following Umbilical Cord Blood Transplant Using Busulfan-Based, Myeloablative Non-TBI Conditioning Regimens.” In Biology of Blood and Marrow Transplantation, 20:S63–S63. Elsevier BV, 2014. https://doi.org/10.1016/j.bbmt.2013.12.071.Full Text
-
McFarren, Alicia, Kristin Page, Suhag Parikh, Paul L. Martin, Timothy A. Driscoll, Joanne Kurtzberg, and Vinod K. Prasad. “Unrelated Umbilical Cord Blood Transplant for Diamond-Blackfan Anemia.” In Biology of Blood and Marrow Transplantation, 20:S177–S177. Elsevier BV, 2014. https://doi.org/10.1016/j.bbmt.2013.12.288.Full Text
-
Prasad, Vinod K., Adam Mendizabal, Kristin Page, Suhag Parikh, Jessica Wishnew, Timothy A. Driscoll, Paul L. Martin, and Joanne Kurtzberg. “Interplay of Recipient-Donor Matching for HLA, Race/Ethnicity and Gender on Long Term Outcomes in 365 Pediatric Recipients of Single 4/6 Matched Unrelated Cord Blood Transplantation (UCBT) after Myeloablative Therapy.” In Biology of Blood and Marrow Transplantation, 20:S87–88. Elsevier BV, 2014. https://doi.org/10.1016/j.bbmt.2013.12.111.Full Text
-
Ramsey, Laura B., John C. Panetta, Colton Smith, Wenjian Yang, Yiping Fan, Naomi Winick, Paul L. Martin, et al. “A Genome-Wide Analysis of Variants Influencing Methotrexate Clearance Replicates SLCO1B1.” In Blood, 120:2466–2466. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.2466.2466.Full Text
-
Richardson, Paul G., Angela Smith, Nancy A. Kernan, Stephan A. Grupp, Sally Arai, Brandon M. Triplett, Paul R. Haut, et al. “Results of a Large Prospective Study On the Use of Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Hematopoietic Stem Cell Transplant (HSCT). Early Intervention Improves Outcome – Updated Results of a Treatment IND (T-IND) Expanded Access Protocol.” In Blood, 120:738–738. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.738.738.Full Text
-
Yang, Jun J., Cheng Cheng, Devidas Meenakshi, Xueyuan Cao, Dario Campana, Wenjian Yang, Yiping Fan, et al. “Genome-Wide Association Study Identifies Germline Polymorphisms Associated with Relapse of Childhood Acute Lymphoblastic Leukemia.” In Blood, 120:878–878. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.878.878.Full Text
-
Yang, Jun J., Heng Xu, Wenjian Yang, Virginia Perez-Andreu, Meenakshi Devidas, Yiping Fan, Cheng Cheng, et al. “Genome-Wide Association Study Identifies a Novel Susceptibility Locus At 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethinically Diverse Populations.” In Blood, 120:877–877. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.877.877.Full Text
-
Richardson, Paul G., Angela R. Smith, Stephan A. Grupp, Nancy A. Kernan, Sally Arai, Paul R. Haut, Brandon M. Triplett, et al. “Defibrotide (DF) in the Treatment of Hepatic Veno-Occlusive Disease (VOD) in Stem Cell Transplant (SCT) and Non-SCT Patients (Pts): Early Intervention Improves Outcome - Updated Results of a Treatment IND Expanded Access Protocol.” In Blood, 118:226–27. AMER SOC HEMATOLOGY, 2011.Link to Item
-
Bain, M. E., P. L. Martin, S. Kojis, S. B. Trout, and J. Kurtzberg. “Meeting the Challenge: Developing a Model to Care for an Adolescent Patient With Leukemia and Severe Autism.” In Biology of Blood and Marrow Transplantation, 17:S283–S283. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.391.Full Text
-
Edmisten, J. H., J. Prewitt, P. L. Martin, and K. Little. “Caregivers Helping in Relieving Pain – C.H.I.R.P. Project.” In Biology of Blood and Marrow Transplantation, 17:S361–S361. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.621.Full Text
-
Mahadeo, K. M., S. H. Parikh, T. A. Driscoll, K. Page, P. Szabolcs, P. L. Martin, J. Kurtzberg, and V. K. Prasad. “Durable Engraftment and Correction of Genetic Defect in Children with Congenital Amegakaryocytic Thrombocytopenia Following Myeloablative Umbilical Cord Blood Transplantation.” In Biology of Blood and Marrow Transplantation, 17:S256–S256. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.312.Full Text
-
Parikh, S. H., P. L. Martin, T. A. Driscoll, J. Baker, K. Piersol, J. Moffet, A. Stokhuyzen, J. Cash, J. Kurtzberg, and P. Szabolcs. “A Prospective Study of Reduced Intensity Conditioning (RIC) in Children Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT) for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of GVHD.” In Biology of Blood and Marrow Transplantation, 17:S265–66. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.338.Full Text
-
Prasad, V. K., A. Mendizabal, P. Tewari, K. Page, S. H. Parikh, P. Szabolcs, T. A. Driscoll, P. L. Martin, and J. Kurtzberg. “Differential Impact of HLA-A, -B, and -DRB1 Mismatching in Relation to Other Variables on the Outcomes of Myeloablative Unrelated Single Donor Umbilical Cord Blood Transplantation From 4/6 Matched Units in Children and Young Adults.” In Biology of Blood and Marrow Transplantation, 17:S185–86. Elsevier BV, 2011. https://doi.org/10.1016/j.bbmt.2010.12.100.Full Text
-
Parikh, Suhag H., Paul L. Martin, Timothy A. Driscoll, Jennifer Baker, Ketti Piersol, Jerelyn Moffet, Andre Stokhuyzen, Joanne Kurtzberg, and Paul Szabolcs. “Reduced Intensity Conditioning In Children Undergoing Unrelated Umbilical Cord Blood Transplantation for Non-Malignant Diseases: Preliminary Results Demonstrate a High Rate of Engraftment and Low Incidence of Gvhd.” In Blood, 116:1453–54. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Richardson, Paul G., Gideon Steinbach, Nancy Kernan, Eva C. Guinan, Allen R. Chen, Paul L. Martin, Amrita Krishnan, et al. “Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC).” In Blood, 116:1430–31. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Richardson, Paul, Angela Smith, Sally Arai, Stephan A. Grupp, Nancy A. Kernan, Roberta Adams, Paul L. Martin, et al. “Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF): Results of a Treatment IND Expanded Access Protocol.” In Blood, 116:399–400. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Yang, Jun, Heng Xu, Cheng Cheng, Meenakshi Devidas, Deqing Pei, Yiping Fan, Wenjian Yang, et al. “ARID5B Genetic Polymorphisms Contribute to Racial Disparities In Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.” In Blood, 116:9–10. AMER SOC HEMATOLOGY, 2010.Link to Item
-
Parikh, S. H., P. L. Martin, V. K. Prasad, P. Szabolcs, G. Ciocci, T. A. Driscoll, and J. Kurtzberg. “Outcomes Of Matched Related Donor Hematopoietic Stem Cell Transplantation In Pediatric Patients With Myelodysplastic Syndrome.” In Biology of Blood and Marrow Transplantation, 16:S248–49. Elsevier BV, 2010. https://doi.org/10.1016/j.bbmt.2009.12.282.Full Text
-
Tewari, P., P. L. Martin, S. H. Parikh, P. Szabolcs, K. M. Page, T. A. Driscoll, J. Kurtzberg, and V. K. Prasad. “Correction Of Immune Defect, Excellent Survival, And Long-Term Donor Chimerism In Children With Chronic Granulomatous Disease After Myeloablative Transplantation Across Donor And Graft Sources.” In Biology of Blood and Marrow Transplantation, 16:S185–S185. Elsevier BV, 2010. https://doi.org/10.1016/j.bbmt.2009.12.104.Full Text
-
Richardson, Paul, Marcie Tomblyn, Nancy Kernan, Joel A. Brochstein, Shin Mineishi, Amanda Termuhlen, Sally Arai, et al. “Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control.” In Blood, 114:272–73. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Tewari, Priti, Susan Wood, Paul L. Martin, Suhag H. Parikh, Paul Szabolcs, Kristin M. Page, Timothy Driscoll, Joanne Kurtzberg, and Vinod K. Prasad. “Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.” In Blood, 114:1319–1319. AMER SOC HEMATOLOGY, 2009.Link to Item
-
Hwang, E. I., M. G. W. Camitta, R. Vinesett, A. Mendizabal, S. Wood, D. Semmel, K. Page, et al. “Pericardial Effusion Following Unrelated Umbilical Cord Blood Transplantation: Analysis in a Cohort Of 423 Pediatric Patients Transplanted at a Single Center.” In Biology of Blood and Marrow Transplantation, 15:73–74. Elsevier BV, 2009. https://doi.org/10.1016/j.bbmt.2008.12.228.Full Text
-
Parikh, S. H., A. Mendizabal, B. Betz-Stablein, P. L. Martin, P. Szabolcs, V. K. Prasad, T. A. Driscoll, and J. Kurtzberg. “Outcomes of Unrelated Umbilical Cord Blood Transplantation In Pediatric Patients With Primary and Secondary Myelodysplastic Syndromes.” In Biology of Blood and Marrow Transplantation, 15:72–72. Elsevier BV, 2009. https://doi.org/10.1016/j.bbmt.2008.12.225.Full Text
-
Prasad, V. K., A. Mendizabal, P. Gill, S. H. Parikh, P. Szabolcs, T. A. Driscoll, K. Page, et al. “Unrelated Umbilical Cord Blood Transplantation From A Single 4/6 Matched Unit is an Effective Therapy for Children With Malignant and Non-Malignant Diagnoses: Good Survival, Low Graft Failure and Graft-vs-Host Disease in a Single Center Analysis of 314 Patients.” In Biology of Blood and Marrow Transplantation, 15:27–27. Elsevier BV, 2009. https://doi.org/10.1016/j.bbmt.2008.12.080.Full Text
-
Prasad, Vinod K., Premjit Gill, Richard Vinesett, Suhag H. Parikh, Paul Szabolcs, Timothy A. Driscoll, Kristin M. Page, et al. “Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients.” In Blood, 112:690–690. AMER SOC HEMATOLOGY, 2008.Link to Item
-
Coppell, J. A., P. G. Richardson, P. L. Martin, M. Iacobelli, E. Carreras, T. Ruutu, T. Barbui, R. Soiffer, and D. Niederwieser. “Incidence of hepatic veno-occlusive disease following stem cell transplantation: systematic review of literature from 1979-2007.” In Bone Marrow Transplantation, 41:S91–S91. NATURE PUBLISHING GROUP, 2008.Link to Item
-
Kelly, Staba S., A. Shahlaee, P. Szabolcs, T. Driscoll, D. Eslin, J. Kurtzberg, and P. L. Martin. “UNRELATED DONOR UMBILICAL CORD BLOOD TRANSPLANT FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH).” In Biology of Blood and Marrow Transplantation, 14:75–75. ELSEVIER SCIENCE INC, 2008.Link to Item
-
Mohamed, A., D. Niedzwiecki, J. H. Baker, R. Vinesett, P. L. Martin, T. A. Driscoll, V. K. Prasad, S. Parikh, J. Kurtzberg, and P. Szabolcs. “208: The Use, Safety, and Efficacy of Daclizumab for Steroid Refractory Graft-Versus-Host-Disease (GVHD) after Unrelated Cord Blood Transplantation (UCBT).” In Biology of Blood and Marrow Transplantation, 14:77–77. Elsevier BV, 2008. https://doi.org/10.1016/j.bbmt.2007.12.217.Full Text
-
Parikh, S. H., A. Mendizabal, P. L. Martin, P. Szabolcs, V. K. Prasad, T. A. Driscoll, and J. Kurtzberg. “224: Outcomes of Unrelated Umbilical Cord Blood Transplantation in Pediatric Patients with Myelodysplastic Syndrome.” In Biology of Blood and Marrow Transplantation, 14:83–84. Elsevier BV, 2008. https://doi.org/10.1016/j.bbmt.2007.12.233.Full Text
-
Prasad, V. K., A. Mendizabal, S. H. Parikh, P. Szabolcs, T. Driscoll, K. Page, S. Lakshinarayanan, et al. “63: Outcomes of Unrelated Umbilical Cord Blood Transplantation in 159 Young Patients with Peroxisomal and Lysosomal Storage Disorders at a Single Center.” In Biology of Blood and Marrow Transplantation, 14:26–26. Elsevier BV, 2008. https://doi.org/10.1016/j.bbmt.2007.12.071.Full Text
-
Prasad, Vinod K., Adam Medizabal, Suhag H. Parikh, Paul Szabolcs, Timothy A. Driscoll, Kristin Page, Sonali Lakshminarayanan, et al. “Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.” In Blood, 110:336–336. American Society of Hematology, 2007. https://doi.org/10.1182/blood.v110.11.336.336.Full Text
-
Bradley, M., L. Baldinger, M. Bhatia, J. Garvin, D. George, E. Roman, P. Satwani, P. L. Martin, J. Kurtzberg, and M. S. Cairo. “A pilot study of myeloablative (MA) autologous stem Cell (Auto SCT) followed by reduced intensity (RI) allogeneic transplantation (AlloSCT) in children with relapsed/refractory(R/R) Hodgkin's disease (HD).” In Journal of Clinical Oncology, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.Link to Item
-
Parikh, S. H., A. Mendizabal, P. L. Martin, P. Szaboles, V. K. Prasad, T. A. Driscoll, and J. Kurtzberg. “Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndrome.” In Biology of Blood and Marrow Transplantation, 13:64–65. ELSEVIER SCIENCE INC, 2007.Link to Item
-
Baker, J. H., P. L. Martin, T. Driscoll, P. Szabolcs, J. Allison, K. Gurganus, G. Ciocci, S. Parikh, V. Prasad, and J. Kurtzberg. “377: Outcomes of pediatric patients transplanted a second time after experiencing graft failure with unrelated donor umbilical cord blood transplantation.” In Biology of Blood and Marrow Transplantation, 13:137–137. Elsevier BV, 2007. https://doi.org/10.1016/j.bbmt.2007.01.007.Full Text
-
Parikh, S. H., P. L. Martin, V. K. Prasad, P. Szabolcs, T. A. Driscoll, and J. Kurtzberg. “173: Outcomes of matched related donor bone marrow transplantation in pediatric patients with myelodysplastic syndrome.” In Biology of Blood and Marrow Transplantation, 13:64–64. Elsevier BV, 2007. https://doi.org/10.1016/j.bbmt.2006.12.177.Full Text
-
Szabolcs, P., P. L. Martin, S. Parikh, V. K. Prasad, R. Vinesett, M. L. Escolar, and J. Kurtzberg. “180: Chronic graft-versus host disease (GVHD) in children with mucopolysacharidoses (MPS) two years after unrelated donor umbilical cord blood transplantation (UCBT).” In Biology of Blood and Marrow Transplantation, 13:67–67. Elsevier BV, 2007. https://doi.org/10.1016/j.bbmt.2006.12.184.Full Text
-
Richardson, Paul, R. J. Soiffer, J. H. Antin, Z. Jin, J. Kurtzberg, P. L. Martin, G. Steinbach, et al. “Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.” In Blood, 108:17A-18A. AMER SOC HEMATOLOGY, 2006.Link to Item
-
Borowitz, Michael J., Meenakshi Devidas, W Paul Bowman, William L. Carroll, I-Ming Chen, Richard Harvey, Stephen Hunger, et al. “Prognostic Significance of Minimal Residual Disease (MRD) in Childhood B-Precursor ALL and Its Relation to Other Risk Factors. A Children’s Oncology Group (COG) Study.” In Blood, 108:219–219. American Society of Hematology, 2006. https://doi.org/10.1182/blood.v108.11.219.219.Full Text
-
Lakshminarayanan, Sonali, Paul Szabolcs, Vinod Prasad, Suhag Parikh, Susan Wood, Gilbert Ciocci, Lauren Stafford, et al. “Acute Graft Versus Host Disease (GVHD) Is Increased in Patients Receiving Cyclosporine/Cellcept as Frontline Prophylaxis Against GVHD in Pediatric Patients Undergoing Allogeneic Stem Cell Transplantation.” In Blood, 108:2896–2896. American Society of Hematology, 2006. https://doi.org/10.1182/blood.v108.11.2896.2896.Full Text
-
Prasad, Vinod K., Juan Wu, Paul L. Martin, Timothy A. Driscoll, Suhag H. Parikh, Deborah Semmel, Jerelyn Moffet, et al. “Melphalan Containing Cytoreduction Results in a Good Overall Survival (OS) in Pediatric Patients with Relapse or Refractory AML Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT).” In Blood, 108:3150–3150. American Society of Hematology, 2006. https://doi.org/10.1182/blood.v108.11.3150.3150.Full Text
-
Guess, C., M. A. Frey, P. L. Martin, and J. Kurtzberg. “Patient controlled analgesia by proxy.” In Biology of Blood and Marrow Transplantation, 12:159–60. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.495.Full Text
-
Lakshminarayanan, S., P. L. Martin, P. Szabolcs, T. Driscoll, S. Parikh, V. Prasad, and J. Kurtzberg. “Cellcept/cyclosporine as prophylaxis against graft- versus-host disease in pediatric patients undergoing allogeneic stem cell transplantation.” In Biology of Blood and Marrow Transplantation, 12:67–68. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.212.Full Text
-
Martin, P. L., T. A. Driscoll, P. Szabolcs, S. H. Parikh, V. K. Prasad, and J. Kurtzberg. “Busulfan/melphalan is an effective and well tolerated conditioning regimen for pediatric AML and MDS patients receiving a matched sibling BMT.” In Biology of Blood and Marrow Transplantation, 12:127–127. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.389.Full Text
-
Prasad, V. K., J. Wu, S. H. Parikh, T. A. Driscoll, P. Szabolcs, P. L. Martin, S. Carter, and J. Kurtzberg. “Single center experience of unrelated umbilical cord blood transplantation (UCBDT) for acute myeloid leukemia (AML) in 97 pediatric patients: Impact of disease status and cytoreductive regimen.” In Biology of Blood and Marrow Transplantation, 12:124–124. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.381.Full Text
-
Summers, E., J. Edmisten, P. L. Martin, M. Frey, and J. Kurtzberg. “Veno Occulsive disease: A potentially life threatening complication of hematopoietic stem cell transplantation.” In Biology of Blood and Marrow Transplantation, 12:161–161. Elsevier BV, 2006. https://doi.org/10.1016/j.bbmt.2005.11.500.Full Text
-
Richardson, P. G., R. J. Soiffer, J. H. Antin, Z. Jin, J. Kurtzberg, P. L. Martin, D. Hockenbery, et al. “Defibrotide (DF) for the treatment of Veno-Occlusive Disease (VOD) and multi-system organ failure (MOF) post SCT: Analysis of response and survival according to degree and type of MOV.” In Blood, 106:120A-120A. AMER SOC HEMATOLOGY, 2005.Link to Item
-
Kokoszka, A. K., M. A. Frey, G. Talbert, and P. L. Martin. “Infection in the pediatric patient after bone marrow or stem cell transplantation: Nursing considerations.” In Biology of Blood and Marrow Transplantation, 11:100–100. Elsevier BV, 2005. https://doi.org/10.1016/j.bbmt.2004.12.297.Full Text
-
Kurtzberg, J., P. Szabolcs, S. Wood, G. Ciocci, T. Driscoll, V. Prasad, S. Parikh, P. L. Martin, J. Allison, and M. L. Escolar. “Treatment of pediatric patients with Sanfilippo syndrome (MPS IIIA and IIIB) with unrelated umbilical cord blood transplantation.” In Biology of Blood and Marrow Transplantation, 11:83–84. Elsevier BV, 2005. https://doi.org/10.1016/j.bbmt.2004.12.246.Full Text
-
Parikh, S. H., P. L. Martin, P. Szabolcs, S. Ann, V. Prasad, T. Driscoll, and J. Kurtzberg. “Outcomes of unrelated umbilical cord blood transplantation in pediatric patients with myelodysplastic syndrome.” In Biology of Blood and Marrow Transplantation, 11:80–80. Elsevier BV, 2005. https://doi.org/10.1016/j.bbmt.2004.12.236.Full Text
-
Stanton, T. J., P. L. Martin, and G. Talbert. “Management of cytomegalovirus in the pediatric bone marrow/stem cell transplantation population.” In Biology of Blood and Marrow Transplantation, 11:104–104. Elsevier BV, 2005. https://doi.org/10.1016/j.bbmt.2004.12.314.Full Text
-
Davies, S. M., M. Borowitz, M. Devidas, N. Winick, P. L. Martin, P. Bowman, J. Elliott, S. Linda, E. H. Cook, and M. V. Relling. “Pharmacogenetics of minimal residual disease response in children with acute lymphoblastic leukemia (ALL).” In Blood, 104:132A-132A. AMER SOC HEMATOLOGY, 2004.Link to Item
-
Borowitz, Michael J., D Jeanette Pullen, Naomi Winick, P. L. Martin, W Paul Bowman, and Bruce Camitta. “Comparison of Diagnostic and Relapse Flow Cytometry Phenotypes in Childhood ALL: Implications for Residual Disease (MRD) Detection.” In Blood, 104:1091–1091. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.1091.1091.Full Text
-
Richardson, Paul G., R. J. Soiffer, J. H. Antin, S. D. Voss, Z. Jin, J. Kurtzberg, P. L. Martin, et al. “Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Final Results of a Phase II, Multicenter, Randomized Study and Preliminary Analyses of Surrogate Markers and Ultrasound Findings.” In Blood, 104:350–350. American Society of Hematology, 2004. https://doi.org/10.1182/blood.v104.11.350.350.Full Text
-
Allison, J., P. L. Martin, P. Szabolcs, T. Driscoll, S. Parikh, S. Wood, and J. Kurtzberg. “Transplantation of boys with X-linked adrenoleukodystrophy with unrelated-donor, partially HLA-mismatched banked umbilical cord blood.” In Biology of Blood and Marrow Transplantation, 10:74–74. Elsevier BV, 2004. https://doi.org/10.1016/j.bbmt.2003.12.100.Full Text
-
Archambault, B. L., T. A. Driscoll, L. A. Stafford, P. Szabolcs, J. Kurtzberg, and P. L. Martin. “Unrelated umbilical cord blood transplantation for familial erythrophagocytic lymphohistiocytosis.” In Biology of Blood and Marrow Transplantation, 10:79–80. Elsevier BV, 2004. https://doi.org/10.1016/j.bbmt.2003.12.132.Full Text
-
Staba, S. L., P. Szabolcs, T. Driscoll, P. L. Martin, and J. Kurtzberg. “Second hematopoietic stem cell transplant using unrelated donor umbilical cord blood cures 50% of pediatric patients with leukemia relapsing after prior allogeneic transplant from a matched related sibling.” In Biology of Blood and Marrow Transplantation, 10:38–38. Elsevier BV, 2004. https://doi.org/10.1016/j.bbmt.2003.12.179.Full Text
-
Kurtzberg, J., P. Szabolcs, P. L. Martin, T. Driscoll, T. Kelly, G. Ciocci, and M. L. Escolar. “Unrelated donor umbilical cord blood transplantation for X-linked adrenoleukodystrophy.” In Blood, 102:479B-479B. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Richardson, P., R. J. Soiffer, J. H. Antin, Z. Jin, J. J. Vredenburgh, J. Kurtzberg, P. L. Martin, et al. “Defibrotide (DF) is effective in the treatment of severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT): Results of a phase II, multicenter, randomized study.” In Blood, 102:193A-193A. AMER SOC HEMATOLOGY, 2003.Link to Item
-
Archambault, B. L., T. Driscoll, P. Szabolcs, J. Kurtzberg, and P. L. Martin. “Unrelated umbilical cord blood transplant for Wiskott-Aldrich syndrome.” In Blood, 100:855A-855A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Kurtzberg, J., P. L. Martin, T. Driscoll, M. Mustafa, S. Wood, T. Kelly, and P. Szabolcs. “Correction of congenital immunodeficiency disease with umbilical cord blood transplantation.” In Blood, 100:858A-858A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
Richardson, P. G., R. Soiffer, J. H. Antin, J. Vredenburgh, J. Kurtzberg, P. L. Martin, D. Hockenbery, et al. “Defibrotide (DF) appears effective and safe in a phase II, randomized study of patients (pts) with severe veno-occlusive disease (VOD) and multi-system organ failure (MOF) post stem cell transplantation (SCT).” In Blood, 100:112A-112A. AMER SOC HEMATOLOGY, 2002.Link to Item
-
-
- Teaching & Mentoring
-
Recent Courses
- Scholarly, Clinical, & Service Activities
-
Clinical Activities
-
Medical Director for the Children's Health Center
Medical Director for the Valvano Day Hospital
-
Medical Director for the Children's Health Center
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.